XELODA 150
Generic Name: capecitabine
Pill imprint XELODA 150 has been identified as Xeloda 150 mg.
Xeloda is used in the treatment of colorectal cancer; stomach cancer; pancreatic cancer; breast cancer; breast cancer, metastatic (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy.
Xeloda 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Xeloda Images
- Generic Name:
- capecitabine
- Imprint:
-
XELODA
150 - Strength:
- 150 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
croscarmellose sodium
hypromellose 2208 (15000 mPa.s)
microcrystalline cellulose
magnesium stearate
water
magnesium silicate
titanium dioxide
ferric oxide red
ferric oxide yellow
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Roche Laboratories
- National Drug Code (NDC):
- 00004-1100
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4143 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Xeloda resources
Search Again
